Use of high-dose liposomal amphotericin B: efficacy and tolerance.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Acta bio-medica : Atenei Parmensis

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17370566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-dose weekly AmBisome antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.

  2006cited by this paper
• Pharmacokinetic-Pharmacodynamic Comparison of Amphotericin B (AMB) and Two Lipid-Associated AMB Preparations, Liposomal AMB and AMB Lipid Complex, in Murine Candidiasis Models

  2006cited by this paper
• Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.

  2005cited by this paper
• Clinical utility of antifungal pharmacokinetics and pharmacodynamics

  2004cited by this paper
• Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis.

  2003cited by this paper
• Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.

  2001cited by this paper
• Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected withAspergillus Species and Other Filamentous Fungi: Maximum Tolerated Dose Study

  2001cited by this paper
• Zygomycosis in relapsed acute leukaemia.

  2000cited by this paper
• Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B.

  1998cited by this paper

• IN VITRO CHARACTERIZATION OF ANTIFUNGAL ACTIVITY OF SELECTED ESSENTIAL OILS

  2021cites this paper
• Antifungal activity of various plant oils against yeast isolates from ICU patients

  2017cites this paper
• Susceptibility characterisation of Candida spp. to four essential oils

  2015cites this paper
• Agents of Mucormycosis and Entomophthoramycosis

  2014cites this paper
• STUDIES ON PHENOTYPIC CHARACTERIZATION AND SELECTIVE VIRULENCE FACTORS OF CANDIDA SPP . AND CRYPTOCOCCUS NEOFORMANS AND IN VITRO SUSCEPTIBILITY OF THESE ORGANISMS TO THE CONVENTIONAL AMPHOTERICIN B AND FUNGISOME

  2014cites this paper
• Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)

  2013cites this paper
• Blastomycosis.

  2012cites this paper
• Research article PREVALENCE OF BIOFILM PRODUCING MDR CANDIDA ALBICANS AND NON CANDIDA ALBICANS ISOLATE FROM MEDICAL DEVICES

  2012cites this paper
• Section 3: Prevention and Treatment of AKI

  2012cites this paper
• Section 4: Contrast-induced AKI

  2012cites this paper
• Liposomes Coloaded with Iopamidol/Lipiodol as a RES-Targeted Contrast Agent for Computed Tomography Imaging

  2010cites this paper
• A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever.

  2009cites this paper
• Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new data.

  2008cites this paper
• SUCCESSFUL COMBINATION OF ANTIFUNGAL AGENTS AND SURGICAL RESECTION FOR PULMONARY ASPERGILLOSIS IN A CHILD WITH HODGKIN DISEASE: Review of the Literature

  2007cites this paper
• References

  1966cites this paper